Suppression of experimental allergic encephalomyelitis in Lewis rats after elimination of macrophages by unknown
Suppression of Experimental Allergic
Encephalomyelitis in Lewis Rats After Elimination of
Macrophages
By Ingeborg Huitinga,* Nico van Rooijen; Corline J. A. de Groot,
Bernard M. J. Uitdehaag,$ and Christine D. Dijkstra*
From the 'Department of Cell Biology, Medical Faculty, Vrije Universiteit; and the
#Department of Neurology, Academic Hospital of the Vriy'e Universiteit, 1007 MC Amsterdam,
The Netherlands
Summary
Almost 50% of the cells infiltrating the central nervous system (CNS) of animals with experimental
allergic encephalomyelitis (EAE) are macrophages (M(p) . To investigate the role of the M(p in
the pathogenesis ofEAE, we eliminated Mcp by means of mannosylated liposomes containing
dichloromethylene diphosphonate (C12MDP) . C12MDP-containing liposomes injected intra-
venously eliminate M(p in spleen and liver. Incorporation ofmannose into the lipid layers enables
the liposomes to pass the blood-brain barrier (BBB) . Injections of C12MDP-containing mannose
liposomes intravenously shortly before the appearance of clinical signs, markedly suppressed the
expression of clinical signs ofEAE . This suppression was accompanied by a marked reduction
of infiltrated M(p in the CNS. C12MDP-containing liposomes without mannose incorporated had
no effect . C12MDP-containing mannosylated liposomes had no effect on plasma corticosterone
levels compared with injections of saline ; thus, the suppression of expression of EAE was not
corticosterone mediated . These results show that the M(p within the CNS play an important
role in the pathogenesis of EAE .
Experimental allergic encephalomyelitis (EAE)t is an in-
flammatory demyelinating disease of the central nervous
system (CNS), which can be induced in genetically suscep-
tible animals by an injection ofwhole nervous tissue homog-
enate emulsified in CFA . On clinical and pathological grounds
EAE is considered to represent an animal model forimmune-
inflammatory diseases of the CNS in general, and for mul-
tiple sclerosis (MS) in particular (1) . About 10-12 d after sen-
sititation the animal starts to exhibit neurological signs caused
by the effects of mononuclear cells infiltrating the CNS,
forming perivascular cuffs. The invading cells mainly consist
ofT cells and macrophages (M(p) and to a lesser extent of
B cells (2-5) .
EAE is considered to be a T cell-dependent, delayed type
of hypersensitivity reaction . It is not clear, however, by which
mechanism cell-mediated immunity initiates clinical and patho-
A report of part of this work will be published in abstract form (Ann .
NY Acad. Sci. 1990. 594:458) .
1 Abbreviations used in this paper : BBB, blood-brain barrier; C12MDP,
dichloromethylene diphosphate ; CNS, central nervous system ; EAE,
experimental allergic encephalomyelitis; EAN, experimental allergic neuritis ;
GSC, guinea pig spinal cord ; M`o, macrophages ; MS, multiple sclerosis ;
PC-liposomes, liposomesconstructed ofphosphatidylcholine and cholesterol ;
PCMAN-liposomes, mannosylated PC-liposomes; p.i ., post-immunization .
logical expression ofEAE . In a previous studywe have shown
that M(p are present in large numbers in the CNS ofEAE
animals (6) . It is very likely that these cells play a role in
the development of tissue damage in the CNS and subse-
quent neurological disorders . M(p have been demonstrated
to strip offmyelin from axons (7) and to phagocytize myelin
in a receptor-mediated way (8) . Furthermore, activated Mcp
secrete numerous products that can play multiple roles in
nonspecific inflammatory reactions underlying breakdown of
the blood-brain barrier (BBB), the attraction ofimmunocom-
petent cells into the CNS, the activation ofimmunocompe-
tent cells, the generation of edema, and degradation of my-
elin (9) . In vitro degradation of myelin byM p products such
as neutral proteinases (10), oxygen radicals (11), and TNF
(12) has been demonstrated . Blood monocytes ofMS patients
show an increased oxidative burst activity (13) . Increased levels
ofproteinases are found in lesions ofMS brains (14) andEAE
CNS (15) . Indeed, administration of both proteinase inhibi-
tors (16, 17) and oxygen radical scavengers (18), suppresses
the expression ofEAE or experimental allergic neuritis (EAN),
the peripheral counterpart of EAE .
Depletion of macrophages after injection of silica dust
shortly before and during the appearance of clinical signs in
EAE (19) and EAN (20-22), remarkably attenuates the de-
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cial role in the effector phase of the disease. Silica however,
is known to exert additional effects on other immunocompe-
tent cells (23-25), andthere is no evidence that silica is capable
of passing the BBB. To bypass the side erects of silica we
used an in vivo Mp elimination method, described by van
Rooijen and van Nieuwmegen (26). Mapwere eliminated by
intravenous injections of liposomes constructed of phos-
phatidylcholine andcholesterol and containing dichloromethy-
lene diphosphonate (C12MDP) (C12MDP PC-liposomes).
C12MDP PC-liposomes injected intravenously eliminate al-
most all Map in spleen and liver (26, 27). Free C12MDP is
not toxic; it needs enclosure in liposomes and subsequent
phagocytosis is necessary for its toxic effect. Therefore, only
phagocytes are susceptible (26). To reach the CNS, we used
mannosylated C12MDP PC-liposomes (C12MDP PCMAN-
liposomes). Mannosylated PC-liposomes are, in contrast with
non-mannosylated PC-liposomes, capable of passing theBBB
(28). To causethe liposomes to reach the CNS at the moment
the Map start to infiltrate, we injected the liposomesjust be-
fore the expected expression of clinical signs. We found that
C12MDP PCMAN-liposomes injected on days 8 and 10 post-
immunization (p.i.) completely suppressed or markedly at-
tenuated the expression of EAE. Non-mannosylated C12MDP
PC-liposomes had no effect on expression of EAE. Timing
of the liposome injections appeared to be critical.
Materials and Methods
Animals.
￿
Male Lewis rats were obtained from the Zentralin-
stitut furVersuchstierzucht (Hannover, FRG),housed two to three
animals perplasticcage, andkept understandard conditions, water
and food available ad libitum . The animals had aweight of "180-
200 g at the time of inoculation.
Induction ofEAE.
￿
AcuteEAEwas inducedby asingle subcuta-
neousinjection under Hypnorm anesthesia Oanssen Pharmaceutica,
Beerse, Belgium, i.m., 0.5 ml/kgbodyweight) of 50,ulguinea pig
spinal cord (GSC) homogenate in one hind food pad. This emul-
sion consisted of 1 g GSC in 1 ml saline (0.9%a, NaCI), to which
10 mg Mycobacterium tuberculosis H37 RA, (Difco Laboratories,
Detroit, MI) in 1 ml CFA (Difco laboratories) was added.
Preparation ofLiposomes.
￿
Multilamellar liposomes were prepared
as described(29). Briefly, to prepare thePC-liposomes, 86 mg phos-
phatidylcholine and 8 mg cholesterol (Sigma Chemical Co., St.
Louis, MO) (molar ratio phosphatidylcholine/cholesterol = 6:1,
with a total amount of 140 pmol of lipids) were dissolved in 10
ml chloroform in a 500-ml, round-bottomed flask, dried in vacuo
on a rotary evaporator to form a film. Subsequently the film was
dispersed into liposomes after the addition of PBS (0.15 M NaCl
in 10 mM phosphate buffer, pH 7.4). To enclose C12MDP into
PC-liposomes, 1.89 g C12MDP (maximum soluble amount) was
added to 10 ml PBS. the preparations were kept for 2 h at room
temperature (RT) and sonicated for 3 min at 20°C in a sonicor
(50 Hz) and kept at RT for another2 h. Theliposomeswere cen-
trifuged at 100,000g for 30 min and finally resuspended in 4 ml
PBS. To prepare PCMAN-liposomes, 70.9 mg phosphatidylcho-
line and 10.8 mg cholesterol were dissolved in 8 ml chloroform
and added to 3.6 mgp-aminophenyl-a-D-mannopyranoside (Sigma
Chemical Co., St. Louis, MO), dissolvedin 2 ml methanol, dried
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as describedabove. Themolarratioofphosphatidylcholine/choles-
terol/mannoside of 7:2:1 was chosen according to Umezawa and
Eto (28).The totalamount oflipids was 140pmol.Thedriedlipid
film was dissolved in chloroform and dried once again before the
aqueous phase, with or without C12MDP, was added. Liposomes
were sonicated and centrifuged as described above.
Treatment.
￿
Two experiments are described. In Exp. A timing
of liposome injections is based on data on kinetics of Map
movement into the CNS post-infection. Map start to infiltrate ±
8-10 d p.i. (6). Mannosylated liposomes are detected in the CNS
24-48 h post-injection (28). Therefore, we gave a first injection
ofliposomes 8dp.i., followed 2 dlaterby asecond injection. Three
groups of eight rats each were treated with either 0.9% NaCl,
PBS PCMAN-liposomes (two control groups), or with C12MDP
PCMAN-liposomes 8and 10 d p.i. (2 ml im.). On day 10 p.i. some
blood samples were taken to study the effect ofthe mannose lipo-
someson thecirculating monocytes. On days 15-17p.i.the animals
were killed forhistological examination. At this moment infiltrated
Map are abundantly present in the CNS of EAE rats.
Exp. B was constructed to study(a) effects of Map elimination
at different stages during the induction phase and early effector
phaseof the disease, and(b) effects on the expression ofEAEafter
elimination of Map in spleen andliver by C12MDP PC-liposomes,
which were notmannosylated andnot capable ofpassing theBBB
(30). This experiment consisted of four groups of five rats each
which received two intravenous injections of 2 ml C12MDP
PCMAN-liposomes on days 6 and 8, 7 and 9, and 8 and 10 p.i.,
or two intravenous injections of 2 ml C12MDP PC-liposomes on
days 8 and 10 p.i. Thecontrol group in this experiment consisted
of six rats and received no treatment post-immunization. On day
50 p.i. the animals were killed for histological evaluation.
Clinical Assessment.
￿
Therats were weighedandinvestigated daily
to scorethedevelopment ofneurological signs. Clinical signswere
scored from 0 to 4: 0, no clinical signs; 1, loss of tail tonus and
unsteady gait (partial loss oftail tonus was scored only when regis-
teredon two consecutive days); 2, paresis of thehind legs; 3, com-
pleteparalysis ofthe hind legs or complete lowerpart of thebody;
4, death due to EAE. 2 and 3 are often accompanied by urinary
and fecal incontinence (31).
Histological Techniques.
￿
Animals were anesthetized with hyp-
norm (i.m., 1 ml/kgbodyweight) andkilled by an intracardial in-
jection of 0.5 ml nembutal (Algin BY, Maassluis, The Nether-
lands). Brain, optic nerves, spinal cord, liver, and spleen were
dissected andfrozen in liquid nitrogen andstored at -20or -70°C.
Cryostat sections of 8 I= were cut serially, picked up on glass
slides, anddriedin a containerwith silica gel. Immunocytochem-
istry was applied to examine cellular infiltrates in the CNS and
efficacy of Map elimination by the C12MDP-liposomes in spleen
and liver. The following mAbs were used: mouse anti-pan-T cell
(OX-19), mouseanti-la(OX-4), both from Serotec, Oxford, UK;
mouse anti-rat macrophages (ED1 and ED3) (32); and the mAb
ED8 which recognizes rat Map as well as glialcells (33, 34). ED8
shows a staining pattern comparable with OX-42, which recog-
nizes the iC3b receptor (35). As conjugate a rabbit anti-mouse
IgGtiperoxidase (Dako, Tilburg, TheNetherlands) wasused. An-
tibodies andconjugatewere diluted in 0.01 M PBS (pH 7.4) with
0.2% BSA (Organon Technika, Oss, The Netherlands) and used
in dilutionsbetween 1:100 and 1:400. Allincubations were carried
out horizontally at RT. After incubation with the first antibody
for 45 min, the slides were rinsed in PBS, incubated in conjugate
with 1% normal rat serum for 30 min, andwashed again in PBS.
Peroxidase activity was demonstrated aftera 10-min incubation with
0.5 mg/ml3,3'-diaminobenzidine-tetra-hydrochloride (DAB; Sigmadays post immunization
Chemical Co .) in 0.05 M Tris buffer, pH 7.6, containing 0.03%
H202 . Sections were lightly counterstained with hematoxylin.
Bloodsmears of animals treated with liposomes were air dried
and stained with MayGrunwald-Giemsa dyes (Merck, Darmstadt,
FRG), according to standard histological staining methods.
Determination of Effects of C12MDP PCMAN-Liposomes on
Plasma Corticosteroid Levels.
￿
To exclude the possibility that the effect
of treatment ofEAE was caused by the induction of a stress re-
sponse in the CNSby thePCMAN liposomes and a concomitant
rise in plasma corticosterone levels, we studied the effect of man-,
nosylated liposomeson plasma corticosterone levels. I.ewis rats were
injected intravenously with either 2 ml 0.9% NaCl or 2 ml
C12MDP PCMAN-liposomes . Blood was collected from the tail
at 6, 24, 48, and 72h after the injections, kept on ice in heparin-
containing tubes, centrifuged (100 g, 15 min ; 4°C) and stored at
-20°C until use. Blood was collected within 5 min after the be-
ginning ofan ether anesthesia to prevent elevation ofcorticosterone
levels due to ether stress . Ether causes plasma corticosterone levels
to rise up to 60 lAg/100 ml plasma after 20 min (36, 37). Plasma
corticosterone wasmeasured usingan extraction step with dichloro-
methane followed by a fluorometric determination as described (38) .
Results
EAE-Experiment A
Clinical Data.
￿
Effects of0.9% saline, PBSPCMAN-, and
C12MDP PCMAN-liposomes, all injected 8 and 10 d p.i . (2
ml, i.v.), on clinical signs and weight are shown in Figs . 1
and 2, respectively. 0.9% NaCl and PBS PCMAN-lipo-
some-treated animals expressedEAEas normal, showing the
first neurological signs on day 9.8 ± 0.7 and day 10.8 ±
0.6 p.i . respectively. Clinical signs were spotted until days
14-17 p.i . ; the exact duration can not be given, since 50%
of the animals were still having clinical signs when animals
were killed for histological evaluation. Clinical signs included
flaccid tail and paresis of the hindlegs. In contrast, all ani-
mals that received C12MDP PCMAN-liposomes showed a
striking absence of neurological disorders . Weight loss was
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apparent in all threegroups, though animals in the C12MDR
and PBS PCMAN-liposome group lost a little less weight
than animals in the saline-treated group (difference not statisti-
cally significant) (Fig. 2) .
Histological Evaluation .
￿
Nervous tissue collected 15-17 d
p.i . revealed severe lesions in saline-treated animals. Lesions
contained high numbers ofT cells and M(p, infiltrating the
CNS. The majority of the infiltrating cells were Ia+ .
Throughout theCNS glial cells were also reacting with the
anti-la mAb. Lesions were dominant in submeningeal areas,
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Figure 1 .
￿
Exp. A: Effect of in-
jections of 0.9% NaCl, PBS-
containing PCMAN-liposomes,
and ChMI)P-contaming PCMAN-
liposomes on EAE . Injections con-
tained 2ml volume and weregiven
intravenously on days 8and 10 pi.
Scoring ofclinical signs ofEAE : 0,
no clinical sips; 1, paralysis of tail;
2, incomplete paralysis ofthe hind-
legs; 3, complete paralysis of the
hindlegs ; and 4, death due toEAE.
--- PBS PCMAN liposomes n=8
--- C12MDP PCMAN liposomes n=8
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Figure 2 .
￿
Exp. A: Effect of injections of0.9% NaCl, PBS-containing
PCMAN-liposomes, and C12MDP-containing PCMAN-liposomes on
bodyweight ofEAE rats. Injections contained 2 ml volume and were given
intravenouslyon days 8 and 10pi . Weight is given in percentage of weight
as it was during immunization. On days 4 and 5 p.i . animals were not
weighed. Each group consists of eight rats.
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16 24in regions around the ventricles and areas where nerves leave
or enter the brain and spinal cord . Serial blocks from these
areas ofthe different experimental groups were compared by
two independent observers . A clear reduction of the number
of lesions in PBS- as well as in the C12MDP PCMAN-lipo-
some treated groups was observed . As a consequence the
amount of infiltrated cells was reduced in both groups, al-
though Ox-19+ cells (T cells) and ED1+ and ED3+ cells
(M'p) were clearly present . The M<p in the C12MDP
PCMAN-liposome treated group however, showed a restricted
infiltration into the parenchyma. In these animals ED1+ and
ED3+ cells were spotted in the lumen of the blood vessels
or sticking between endothelial cells ; in many lesions they
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were only sparsely seen outside the blood vessels (Fig .' 3 b) .
This phenomenon was not observed in lesions of saline and
PBS PCMAN-liposome treated animals (Fig. 3 a) . No changes
in glial cell populations could be observed; in particular no
differences were observed in the morphology and number
of ED8+ glial cells of the different experimental groups.
Spleen and liver sections showed efficient elimination of
the M(p by the C12MDP PC- and C12MDP PCMAN-
liposomes as described before (27) . Blood samples collected
on day 10 p .i . (2 d after the first injection), _showed an in-
crease in the ratio ofPMN to lymphocytes . Percentages PMN
ranged from normally 11% in healthy Lewis rats to 39% in
the saline treated, 22% in the PBS PCMAN-liposome, and
Figure 3 . Exp. A : Representative micro-
graphs of 8-jum cryostat sections incubated
with themAb ED1 which specifically recog-
nizes rat Mip, at the medulla oblongata of
animals that had received 0.9% NaCl (a) or
C12MDP containing PCMAN-liposomes (b)
on day 8 and 10 p.i . (both same magnification,
x 250) . Note extensive infiltration oftheCNS
parenchyma by the M(p in the saline-treated
animals, whereas in the CNS ofthe C12MDP-
containing PCMAN-liposome- treated animals
no M(p can be spotted outside the lumen of
the blood vessel . Tissue was collected 16 d p.i.34% in the ClzMDP PCMAN-liposome treated group (Fig.
4) . Percentages are given of counts of 200 white blood cells
per animal . Expanded and vacuolized monocytes made up
8% of the C12MDP PCMAN-liposome and 2.5% of the
PBS PCMAN-liposome-treated animals . Such enlarged and
sometimes disintegrating monocytes were not spotted in
healthy Lewis rats or saline-treated EAE rats. Percentages of
healthy looking monocytes varied between 2% in healthy
Lewis rats, to 3% in the saline-, 7% in the PBS PCMAN-
liposome-, and 2.5% in the C12MDP PCMAN-liposome-
treated EAE group.
EAE-Experiment B
Clinical Data.
￿
The effect ofC12MDP PCMAN-liposomes
injected at three different time points (days 6 and 8, 7 and
9, and 8 and 10 p.i .) and of C12MDP PC-liposomes (days
8 and 10 p.i .) on the expression of clinical signs of EAE is
shown in Fig. 5 and Table 1 . Animals were observed until
day 50 p .i . The control group in this experiment received
no treatment (2-ml i.v. injections of saline at days 8 and 10
p .i . have no effect on expression ofEAE ; unpublished data) .
First signs ofEAE (flaccid tail) were spotted 9.4 ± 1.3 d
p .i . in the C12MDP PC-liposome-treated group, subse-
quently followed by the control animals (10.2 ± 0.4 d), and
the C12MDP PCMAN-liposome groups treated 6 and 8 d
p.i . (10.8 ± 1.0 d), 7 and 9 d p .i . (12.7 ± 0.6 d), and finally
Figure 4 .
￿
ExperimentA : Effect of EAE, 2 ml 0.9% NaCl, 2 ml PBS
containing PCMAN-liposomes, and 2 ml C12MDP containing PCMAN-
liposomes, injected ix ., days 8 and 10 p.i ., on the ratio lympho-
cytes:PMN:monocytes ofthe Lewis rat . Blood samples were taken 10 days
p.i ., this was two days after a first ix. injection of2 ml saline or liposomes.
Blood smears were stained with May Granwald-Giemsa and 200 leuco-
cytes per smear were identified on morphological features and counted.
The average ratio of each experimental group ± SD is represented. Note
the increase in ratio PMNaymphocytes in EAE animals and the increase
in ratio monocytesAymphocytes in the PBS PCMAN-liposomes treated
animals, and the appearance of the group enlarged and vacuolized mono-
cytes. Difference with healthy Lewis rats is statistical significant: " = p
< 0.01 (Wilcoxon Rank sum Test) .
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8 and 10 d p .i . (13.0 ± 0.0 d) (Table 1) . Thus, there was
a correlation between the timing of the injections of
C12MDP PCMAN-liposomes and the day of onset of clin-
ical disease . Severity of the disease was analyzed based on the
number ofanimals that had at least paresis of hindlegs (score
2) . It appeared that C12MDP PCMAN-liposomes injected
7 and 9 d or 8 and 10 d p.i . had the best suppressive effects
on expression of clinical signs ofEAE (p< 0.05) . Incidence
of clinical disease was 60% in these groups, but signs were
restricted to flaccid tails for only a maximum of 3 d . Based
on the incidence of one relapse in the days 7 and 9 group
and on the total number of days during which flaccid tails
(score 1) were scored, EAE in the days 8 and 10 group was
even better suppressed than in the days 7 and 9 group.
EAE was also suppressed in animals that received C12MDP
PCMAN-liposomes 6 and 8 d p.i ., but two relapses occurred
and paresis of the hindlegs occurred during 10 d against 1 d in
each of the other two C12MDP PCMAN-liposome-treated
groups (Fig. 5) . In contrast, animals that were treated with
C12MDP PC-liposomes all developed EAE. Mean day of
onset of clinical disease was, as already mentioned, one day
before that of the controls. Two of five animals did not re-
cover as quickly as animals in the other experimental groups .
One relapse occurred and one animal died due to EAE . Weight
loss was apparent in all five experimental groups and com-
parable to the weight loss seen duringEAE in Exp. A (Fig. 2) .
Histological Evaluation .
￿
Nervous tissue collected 50 d p .i .
showed dim remainders ofmultiple lesions . Lesions in animals
of all experimental groups showed only a very small amount
of infiltrating cells . Pan-T cells were present in some lesions
as were ED1 and very sparse numbers ofED3+ cells . Com-
parison of central nervous tissue of untreated and liposome-
treated groups revealed no difference in the amount of le-
sions and infiltrating panT cells. ED1+ and ED3+ cells,
however, showed a tendency to be present in higher numbers
in animals in which the disease had been most strongly sup-
pressed . Histological evaluation of spleen sections did not
reveal signs of Mcp eliminating activities 6 wk before dis-
section . ED1+ and ED3+ cells were present as normal .
Recovery within 2 mo of M<p in the spleen after depletion
by C12MDP-containing liposomes has been described (27) .
Effect ofC12MDP PCMAN-Liposomes on Plasma
Corticosterone Levels
No difference was observed between the effect of injection
of C12MDP PCMAN liposomes and injection of saline on
the plasma corticosterone levels (Fig . 6) . Plasma corticosterone
levels were in both groups slightly elevated up to 10-18 Fig/100
ml plasma until 3 d after the injections. Basic levels were 4.0
± 1.1 and 4.5 ± 1.4 ug corticosterone/100 ml plasma, respec-
tively. The elevation after the injections is probably caused
by stress reactions due to the injections and repetition ofblood
sampling, and is similar in both groups .
Discussion
The results clearly demonstrate that Lewis rats can be pro-
tected against development of neurological signs ofEAE byrat
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Table 1 .
￿
Effect of Diffrent Liposomes Administered at Different Timepoints on Expression ofEAE
scoring clinical signs of EAE :
0 = no clinical signs
1 = paralysis of tail
2 = incomplete paralysis of hindlegs
3 - complete paralysis of hindlegs
4 = death due to EAE
Figure 5.
￿
Exp . B: Effect of 2 ml CIZMDP-containing PCMAN-liposomes injected intravenously at different timepoints post-immunization (days
b and 8, 7 and 9, and 8 and 10) and CIZMDP-containing PC-liposomes (days 8 and 10 p.i.), on the expression of clinical signs ofEAE .
Exp. B: Effect of 2 ml CIZMDP-containing PCMAN-liposomes (CIZMDP MANL) injected intravenously at different timepoints post-immunization
(days six and eight, seven and nine, and eight and ten) and CIZMDP-containing PC-liposomes (CIZMDP L) (days eight and ten p.i .), on the expres-
sion of clinical signs of EAE. Averages are given ± SD . Difference with control animals is statistically significant: 'p < 0.05 (Xy2 Test) .
Experimental
group
Average day of
clinical onset
± SD Incidence
Average duration of
clinical signs ± SD
Number of animals with
at least paresis of
hindlegs (score 2) Relapses
d
No treatment 10 .2 ± 0.4 100 6 .2 ± 1.4 b/b 0
(n = b)
days b and 8 p.i .
CL ZMDP MANL 10.8 ± 1.0 80 4.3 ± 2.5 2/5 2
(n = 5)
days 7 and 9 p.i .
CIZMDP MANL 12.7 ± 0.6 60 3 .0 ± 0.0 115`
(n = 5)
days 8 and 10 p.i.
CIZMDP MANL 13.0 ± 0.0 60 2.3 ± 1.2 1/5" 0
(n = 5)
days 8 and 10 p.i .
C1 2MDP L 9.4 ± 1 .3 100 9.0 ± 5.4 4/5 1Figure 6 . Effect of 2 ml, iv. injected, 0.9% NaCl and C12MDP-
containing PCMAN-liposomes on plasma corticosterone level at 6 h and
1, 2, and 3 d post-injection. No difference between saline and liposome
effects were observed (Wilcoxon Rank sum Test) . Values given are means
t SD, five animals per group .
intravenous injections of mannosylated C12MDP PC-lipo-
somes shortly before onset of clinical signs. No significant
effect was found on weight loss normally accompanying ex-
pression of EAE. Radioactive labeled mannosylated PC-
liposomes canbe demonstrated in the CNS after intraperitoneal
injection (28) . This is in contrast with radiolabeled non-
mannosylated PC-liposomes, which can not be detected in
theCNS after intravenous injection (30) . Both kinds oflipo-
somes, when containing C12MDP, eliminated Mp in spleen
liver when injected intravenously (27 ; this study) . C12MDP
PC-liposomes without mannose incorporated had no effect
on the expression ofEAE . Elimination ofM(p in spleen and
liver was apparently not sufficient to suppress clinical signs
of EAE . The suppressive effect of the C12MDP PCMAN-
liposomes is therefore likely to be due to elimination ofMrp
infiltrating the CNS.
In contrast to silica (23-25), C12MDP PC-liposomes selec-
tively kill phagocytizing cells (29) and do not affect prolifer-
ation and functions ofT and B cell clones in vitro (39) . Sup-
pression of EAE by C12MDRcontaining liposomes is thus
due to direct or indirect effects of M<p elimination .
Histological evaluation ofCNS tissue revealed a consider-
able reduction of the number of infiltrated M(p in C1 2MDP
PCMAN-liposome-treated animals . This finding supports the
fact that the mannosylated PC-liposomes reach the CNS and
exert their effect there. On light microscopal level no changes
in glial cell populations could be observed .
Recent intriguing data on involvement of corticosteroids
in immune-regulatory eventsshow the need ofelevated plasma
corticosterone levels for spontaneous recovery of rats from
EAE (40, 41) . To rule out the possibility that the C12MDP
PCMAN-liposomes evoke a stress response in the CNS by
stimulating the hypothalamic-pituitary-adrenal axis and
subsequently suppress expression ofEAE by elevation of cor-
ticosterone levels, we studied the effect ofintravenous injections
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Of C12MDP PCMAN-liposomes on plasma corticosterone
levels . No difference in effect was observed on corticosterone
levels between saline and C12MDP PCMAN-liposome injec-
tions. Slight elevations, probably due to the stress induced
by the injections and repetition ofblood sampling under ether
anesthesia were observed, but did not reach corticosteroid
levels ofmore then 30-40 jig/100 ml, which are described
to be necessary for EAE recovery (40) .
Timing of the injections appeared, tobe very important .
Suppression of EAE after C12MDP PCMAN-liposomes in-
jected 6 and 8 d p.i. was not as strong as after C12MDP
PCMAN-liposome injections 7 and 9 and 8 and 10 d p.i .
Injections of C12MDP PCMAN-liposomes on two succes-
sive days post-immunization showed an almost constant time
interval of 3 d between the day of the second injection and
the day of onset of clinical signs (Table 1) . In those 3 d lipo-
somes may partially have been cleared from the blood, and
new monocytesmay have been recruited from the bone marrow
as a source of new activated Map. These MV can then be
responsible for retarded and possibly less severe clinical signs.
This indicates a very quick succession of immunological events,
such as attraction ofimmunocompetent cells into the CNS,
initiation of effector mechanisms resulting in tissue damage,
and subsequent generation of suppressor mechanisms during
acute EAE .
Our results indicate that M(p are essential for the patho-
genesis ofEAE . Sedgwick et al . (42) reported, however, that
CD4+ lymphocytes alone are responsible for the develop-
ment of clinical signs of EAE in irradiated rats after sensiti-
zation with MBP-reactive CD4+ cells. These recipient rats
had only a very few infiltrating cells in the CNS. Hardly any
M(p were present in the CNS, as was demonstrated by the
mAbsW3/25(CD4) (43,44) andMRCOX42 (35) . It must
be noted, however, that neitherW3/25 nor OX-42 are specific
M(p markers, nor do they recognize all Map as does mAb
ED1, for example (32, 35, 43, 44) . Therefore, it is possible
that the Mrp in the lesions of the CNS of the irradiated rats
were not recognized by the used mAbs. Another explana-
tion for the discrepancy between the results of Sedgwick et
al . (42) and our results is that the mechanism that causes
paralysis in the irradiated rats differs from that in unirradi-
ated rats . The pathology in the CNS of irradiated rats in-
cludes, in contrast to the usual EAE models, hemorrhages
that also can cause paralysis. A third possibility is that the
effect ofMap elimination in our study is not caused directly
by the lack ofM(p but by the lack of their stimulatory ac-
tivity for CD4 + cells. Our immunohistochemical findings
reveal no difference in the number and localization ofT cells
in the CNS between animals treated with C12MDP
PCMAN-liposomes and controls .
The difference between the effects of mannosylated and
non-mannosylated C12MDP PC-liposomes was striking.
Mannosylated liposomes are found to pass the BBB (28) . It
is not clear how the liposomes pass the BBB, and Umezawa
and Eto (28) mention mannose as being a "recognition marker"
for an unknown molecule or mechanism . With respect to
the present study, it should be kept in mind that a mannosyl
receptor can be expressed on activated monocytes (45, 46) .This phenomenon leads to a more efficient in vitro binding
of mannosylated liposomes to macrophages (47). However,
both kinds of liposomes, with and without mannose incor-
porated, eliminate Map in spleen and liver equally well after
intravenous injections. In addition, i.v. injections of 2 ml of
C12MDP PCMAN- as well as C12MDP PC-liposomes elim-
inate all monocytes in the blood (Huitinga, I., J.G.M.C.
Damoiseaux, N. VanRooijen, andC.D. Dijkstra, manuscript
submittedfor publication). Elimination ofM<pin spleen and
liverandmonocytesin theblood, was apparently not sufficient
to suppress EAE. This raises the question why silica dust
suppresses EAN (20-22) and EAE (19) . Possible explanations
are thefollowing: (a) silica exerts additional effects on other
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